Vaishali Sanchorawala MD

Professor, Medicine, Boston University School of Medicine

830 Harrison Ave 3rd FLMoakley HematologyoncologyBoston, MA 02118
Phone+1 617-638-6428
Fax+1 617-638-5756

Dr. Sanchorawala is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sanchorawala's full profile Already have an account?

Education & Training

Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1997
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1991 - 1994
Seth G.S. Medical CollegeClass of 1990

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1994 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
COMPLETED
PHASE2
Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis
COMPLETED
PHASE2
HD Melphalan and SCT in Patients With IGDD or LCDD
TERMINATED
PHASE2

Publications & Presentations

PubMed

Structural Basis for the Pro-amyloidogenic Action and Ligand Binding of a Novel W72R Variant of Human Apolipoprotein A-I.
Tatiana Prokaeva, Shobini Jayaraman, Elena S Klimtchuk, Caryn Libbey, Lisa Mendelson
Journal of Molecular Biology. 2026-10-01
Diagnostic utility of immunofixation and free light chain assay in AL amyloidosis: a systematic review and meta-analysis.
Muayad Azzam, Qais Hamarsha, Hassan Kawtharany, Jamil Nazzal, Aseel Alkhader
Blood Advances. 2026-08-11
Rare dual-clone phenomenon: concurrent λ AL amyloidosis and κ restricted B-cell lymphoproliferative disorders.
Okan Cetin, Andrew Staron, Lisa Mendelson, Tracy Joshi, Vaishali Sanchorawala
Haematologica. 2026-08-01

Journal Articles

Development and Validation of a Survival Staging System Incorporating BNP in Patients with Light Chain (AL) Amyloidosis
Frederick L Ruberg, Vaishali Sanchorawala, Blood
Heparin-Induced Thrombocytopenia and Thrombosis During High Dose Melphalan and Autologous Stem Cell Transplantation
Dina Brauneis, Vaishali Sanchorawala, J Mark Sloan, Shayna Sarosiek, Blood

Abstracts/Posters

Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ...
Vaishali Sanchorawala, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Primary Results from the Phase 3 Tourmaline-AL1 Trial of Ixazomib-Dexamethasone Versus PhysicianÍs Choice of Therapy in Patients (Pts) with Relapsed/Refractory Primary...
Vaishali Sanchorawala, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results o...
Vaishali Sanchorawala, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Untangling Amyloidosis 2019
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Vaishali Sanchorawala: Her Pioneering Research into the Rare Disease Amyloidosis Defines the FieldFebruary 24th, 2021
Organ Responses After Highdose Melphalan and Stemcell Transplantation in AL AmyloidosisJuly 31st, 2020
Anti-Cancer Drug Safe and Effective for Treating Light Chain (AL) AmyloidosisFebruary 3rd, 2020